Impact of Smoking on Physical Activity Level in Young Adults
NCT ID: NCT07043920
Last Updated: 2025-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
164 participants
OBSERVATIONAL
2025-07-01
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Smoking Addiction on Lower Limb Speed and Coordination
NCT07061522
Exercise Training for Smoking Students
NCT06291558
Increasing Physical Activity as Part of a Smoking Cessation Program
NCT00403312
Smoking and Health Among University Students
NCT06680570
Evaluation of the Effectiveness of a Very Brief Smoking Cessation Intervention in Family Health Centers
NCT07030387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smoker Group
This group will consist of university students aged 18 years and older who report currently smoking cigarettes on a regular basis. Their level of nicotine dependence will be assessed using the Fagerström Test for Nicotine Dependence (FTND). They will also complete the International Physical Activity Questionnaire-Short Form (IPAQ-SF) to evaluate their weekly physical activity levels.
Behavioral Assessment (No therapeutic intervention will be administered)
Participants will complete two validated questionnaires:
The Fagerström Test for Nicotine Dependence (FTND) - to assess levels of nicotine dependence.
The International Physical Activity Questionnaire - Short Form (IPAQ-SF) - to quantify weekly physical activity levels (walking, moderate, vigorous).
Non-Smoker Group
This group will include university students aged 18 years and older who have never smoked or used tobacco products. Their physical activity levels will be assessed using the IPAQ-SF. FTND will not be applied as they have no smoking history.
Behavioral Assessment (No therapeutic intervention will be administered)
Participants will complete two validated questionnaires:
The Fagerström Test for Nicotine Dependence (FTND) - to assess levels of nicotine dependence.
The International Physical Activity Questionnaire - Short Form (IPAQ-SF) - to quantify weekly physical activity levels (walking, moderate, vigorous).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Assessment (No therapeutic intervention will be administered)
Participants will complete two validated questionnaires:
The Fagerström Test for Nicotine Dependence (FTND) - to assess levels of nicotine dependence.
The International Physical Activity Questionnaire - Short Form (IPAQ-SF) - to quantify weekly physical activity levels (walking, moderate, vigorous).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Studying in a health-related university program
* Healthy individuals (no known chronic disease)
* Voluntarily agreeing to participate
Exclusion Criteria
* Pregnancy
* Age under 18
18 Years
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ESRA PEHLIVAN
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Esra Pehlivan
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FA-Nosmoke-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.